Dubai emerges as a regional hub for gene therapy breakthroughs: Medcare leads the way in transforming lives of children with rare genetic diseases
Medcare has been redefining excellence in the field of paediatric neurology and gene-based therapies, pioneering a new era of hope and healing for families affected by such debilitating conditions. Turkish families are increasingly turning to Medcare for SMA treatments, with incidence rates in Turkey significantly higher than the global average. The hospital's state-of-the-art facilities, international medical expertise, and holistic treatment model position it as a Centre of Excellence for gene disorders, not just in the UAE but across the MENA and the Asia-Pacific regions.
SMA, a rare neurodegenerative condition, causes progressive muscle weakness and often proves fatal in infancy if left untreated. In Turkey, SMA affects 1 in every 6,000 births compared to 1 in 10,000 globally[i]. According to the Turkish health authorities, there are currently over 3,000 people living with SMA, and about 150 new cases are diagnosed each year. DMD, another severe neuromuscular disorder, affects over 4,000 genetically confirmed patients in Turkey[ii].
Under the leadership of Dr. Vivek Mundada, a British Board-certified Consultant Paediatric Neurologist at Medcare Royal Speciality Hospital has delivered remarkable outcomes in managing these complex genetic conditions. Unlike traditional therapies that require ongoing spinal injections, Medcare offers a one-time, potentially curative gene therapy that addresses the root cause of the condition, dramatically improving the quality of life and long-term health. Medcare is the first private healthcare provider outside the U.S.A. to successfully administer gene therapy for SMA in the MENA region, having delivered over 100 infusions to date at Medcare Women & Children Hospital.
'Dubai is becoming a center of medical innovation, and Medcare is proud to be leading that movement, especially in the field of rare genetic diseases,' said Dr. Vivek Mundada, Consultant Paediatric Neurologist at Medcare Royal Speciality Hospital. 'Through our comprehensive, patient-centered care model, we are transforming outcomes for children who previously had limited treatment options.'
Medcare's approach goes beyond clinical excellence. Patients benefit from a multidisciplinary team that includes experts in neurology, pulmonology, orthopaedics, rehabilitation, and genetic counselling. The hospital also provides continuous follow-up care for international patients after they return home.
Turkish families have already seen outstanding results. One such story is that of Mirha, diagnosed with SMA just nine days after she was born. In 2024, she underwent gene therapy at Medcare and is now thriving without the need for breathing or feeding support. Similarly, Elif Bade who was treated in March 2024 when she was just 2 years old, has shown remarkable progress following her gene therapy at Medcare.
The parents of Mirha remarked, 'We cannot express enough gratitude to Dr. Mundada and the Medcare team. Thanks to the expert and compassionate care in Dubai, our daughter has been given a new lease on life.'
Aligned with the UAE's vision to be a global hub for medical innovation and excellence, Medcare continues to invest in infrastructure, talent, and technology to offer best-in-class care. The newly launched rare disease unit at Medcare Royal Speciality Hospital in Dubai offers AI-powered diagnostics, robotic surgery, and advanced quaternary care, reinforcing its leadership in rare disease management.
As part of Aster DM Healthcare, Medcare is committed to expanding access to advanced medical care for international patients, while contributing to the UAE's growing medical tourism sector, where families seek top-tier, cost-effective care without long wait times, especially for critical and time-sensitive conditions like the rare genetic disorders.
[i] Turkey vs. Zolgensma: the battle over a $2.1 million drug – SWI swissinfo.ch
[ii] About Duchenne Muscular Dystrophy – DMD Aileleri (Turkey)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
19-07-2025
- Khaleej Times
'His positivity was half the cure': Athletes remember Dubai-based doctor's care, gentle nature
Patients, athletes, and colleagues are mourning the loss of Dr Anwar Sadath, a well-known orthopedic surgeon in Dubai, who passed away earlier this week at the age of 49. Dr Sadath was from Kerala and was known for his gentle nature, ethical practice, and deep care for his patients. He was a specialist at Medcare Orthopaedics and Spine Hospital and had over 18 years of experience in treating sports injuries, fractures, and trauma cases. For the past 14 years, he was a part of the Aster DM Healthcare group. Among those deeply affected by his passing is Indian international handball player Vipin Kumar, who had been receiving treatment from Dr Sadath for many years. 'He was more than just a doctor to me. He focused on healing my injuries naturally, through strengthening exercises and avoiding unnecessary surgeries. Whenever I got hurt, he gave me the confidence to recover and keep going. He always reminded me that we were in this together, it was a team effort,' said Vipin. Vipin had recently returned from an international handball tournament in Taipei and had met Dr Sadath just days before his death. 'He told me he was going on a vacation soon. He was so happy and proud every time I brought home a medal. I even spoke about him during a recent radio interview, thanking him for the role he played in my success,' he added. Another patient, speaking to Khaleej Times, said Dr Sadath treated everyone like family. 'He wasn't just a doctor; he was a well-wisher. He cared from the heart. He would never suggest unnecessary procedures, and his first step was always to calm us down and lift our spirits before starting any treatment. That positivity alone was half the cure.' Known for his humility, Dr Sadath had a strong connection with many athletes in the UAE. His colleagues described him as a man with a pure heart who always put his patients first. 'He had a gift for making people feel at ease. You walked into his clinic with pain and walked out with hope,' said a colleague. Dr Sadath is survived by his three children. His sudden passing has left a void in the medical and sports community. He is being laid to rest after Asr prayer at Al Qusais Cemetery, with many of his patients and well-wishers attending the funeral.
Gulf Today
18-07-2025
- Gulf Today
Al Jalila Children's Hospital crosses 100 treatments for Spinal Muscular Atrophy
Al Jalila Children's Hospital, part of Dubai Health, and the only children's hospital in the UAE, has completed over 100 treatments for patients with Spinal Muscular Atrophy (SMA). Dr Mohamed Al Awadhi, Executive Director of the Dubai Health Women and Children's Campus, said, "Reaching more than 100 treated cases of SMA reflects Dubai Health's commitment to making world-class care accessible to all children. At Al Jalila Children's Hospital, we follow an integrated, patient-centred approach that supports every phase of the treatment journey. Every step is managed with precision and compassion to put the patient first. Yaqeen's case highlights the strength of our multidisciplinary model and our commitment to ensuring that children with complex conditions like SMA receive the highest standard of care under one roof.' Dr Haitham Elbashir, Consultant Pediatric Neurorehabilitation at Al Jalila Children's Hospital, said, "Zolgensma is a transformative therapy that offers children with SMA the chance to regain strength and function early in life.' The completion of over 100 SMA treatments at Al Jalila Children's reflects the strength of Dubai Health's specialised pediatric services and its commitment to delivering high-quality care for children with complex medical needs. WAM
The National
18-07-2025
- The National
Syrian girl receives life-saving treatment as Dubai Ruler covers Dh7 million cost
A young Syrian girl diagnosed with spinal muscular atrophy received Dh7 million gene therapy paid for by Sheikh Mohammed bin Rashid, Vice President and Ruler of Dubai, on Friday at the emirate's Al Jalila Children's Speciality Hospital. Holding a small giraffe toy, and trying to smile, Yaqeen Kankar, sat in the treatment room on Friday morning waiting for the arrival of doctors and her medicine. Two weeks ago, the family made a video appeal on social media for help to save the two-year-old. The office of Sheikh Mohammed called the family saying the Ruler of Dubai would cover the Dh7 million ($1.9 million) cost of medical treatment. Yaqeen's uncle, Ibrahim Abdulaziz Faroj, told The National the family was relieved to know she could now have a normal life. 'We didn't sleep for three days after receiving the happy news that Sheikh Mohammed would cover the cost,' Mr Faroj, 23, said. 'It's a mix of feelings between joy, anticipation and anxiety. We want her to grow normally like any other child. Thanks to Dubai, the dream becomes true.' The uncle had posted a video holding Yaqeen, explaining her condition and asking for help with the cost of her treatment, which is available at only a few centres in the world. 'We know that she has no time. We didn't have other way than to plea for help as we couldn't afford the cost,' Mr Faroj said. Eight months before moving to Dubai, doctors in Syrian diagnosed Yaqeen with spinal muscular atrophy (SMA), a genetic disorder that weakens and wastes muscles. Her parents left no stone unturned seeking help. 'I was posting about her for several months until we received the happy call,' Mr Faroj said. 'It was the best gift ever. We all cried with joy when we heard the news. This action is not strange for the UAE and its rulers who always help people in desperate need.' Doctors gave Yaqeen only months to live without the expensive treatment. Dr Haitham Elbashir, paediatric neurorehabilitation consultant at Al Jalila Children's Hospital, told The National: 'We examined her a week ago and did all the laboratory tests. I'm very happy to say that the medicine is going to be delivered to her today.' Yaqeen underwent the one-hour procedure on Friday morning and will stay in the hospital for 24 hours. Then she can go with her parents to their home in Sharjah. Doctors said they were optimistic it would be successful, but it could take up to three months to see the final results. 'She will need to continue with us for three months because that's the treatment period where we need to follow her regularly,' said Dr Elbashir. Yaqeen was diagnosed with SMA type 2 when she was only six months old. 'Her condition is stable, but she's got some weakness and hopefully the treatment will help to get her better. I'm very optimistic,' said Dr Elbashir. SMA affects the motor neurons (nerve cells that transmit impulses to the muscles) and weakens the limbs. It makes walking difficult or impossible and creates problems with swallowing, as well as breathing. The treatment offered by Al Jalila Children's Hospital, called Zolgensma, is given once and is a form of gene therapy. It was approved by the US Food and Drug Administration four years ago and has been described as the most expensive drug in the world. The hospital has completed more than 100 treatments for patients with SMA, said Dr Mohamed Al Awadhi, executive director of the Dubai Health Women and Children's Campus.
